U.S. Clot Management Devices Market Size & Outlook

The clot management devices market in the United States is expected to reach a projected revenue of US$ 1,286.7 million by 2030. A compound annual growth rate of 4.7% is expected of the United States clot management devices market from 2024 to 2030.
Revenue, 2023 (US$M)
$934.1
Forecast, 2030 (US$M)
$1,286.7
CAGR, 2024 - 2030
4.7%
Report Coverage
U.S.

U.S. clot management devices market, 2018-2030 (US$M)

U.S.

U.S. clot management devices market highlights

  • The U.S. clot management devices market generated a revenue of USD 934.1 million in 2023 and is expected to reach USD 1,286.7 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 4.7% from 2024 to 2030.
  • In terms of segment, percutaneous thrombectomy devices was the largest revenue generating product in 2023.
  • Neurovascular Embolectomy Devices is the most lucrative product segment registering the fastest growth during the forecast period.


Clot management devices market data book summary

Market revenue in 2023USD 934.1 million
Market revenue in 2030USD 1,286.7 million
Growth rate4.7% (CAGR from 2023 to 2030)
Largest segmentPercutaneous thrombectomy devices
Fastest growing segmentNeurovascular Embolectomy Devices
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationNeurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter-directed thrombolysis (CDT) devices, Inferior vena cava filters (IVCF)
Key market players worldwideMedtronic PLC, Boston Scientific Corp, Teleflex Inc, Edwards Lifesciences Corp, LeMaitre Vascular Inc, Cook Medical, DePuy Synthes, iVascular, Vascular Solutions


Other key industry trends

  • In terms of revenue, U.S. accounted for 51.9% of the global clot management devices market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. clot management devices market is projected to lead the regional market in terms of revenue in 2030.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 199.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Clot Management Devices Market Companies

Name Profile # Employees HQ Website

U.S. clot management devices market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clot management devices market will help companies and investors design strategic landscapes.


Percutaneous thrombectomy devices was the largest segment with a revenue share of 36.16% in 2023. Horizon Databook has segmented the U.S. clot management devices market based on neurovascular embolectomy devices, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis (cdt) devices, inferior vena cava filters (ivcf) covering the revenue growth of each sub-segment from 2018 to 2030.


The U.S. clot management devices market holds a dominant market share of 87.25% in 2022 owing to factors such as growing healthcare expenditure, product innovation, a favorable medical funding environment, the presence of advanced medical technology, and a growing population susceptible to cardiovascular diseases.

For instance, in February 2022, the Peter G. Peterson Foundation article reported that the U.S. healthcare ecosystem was ranked sixth in the 2021 World Index on Healthcare Innovation. Moreover, in the analysis, the U.S. was ranked 1st in medical scientific advancement.

Several research bodies have highlighted a strong correlation between Coronary Artery Disease (CAD) & increased chances of developing blood clots. Moreover, as per CDC, 1 in 20 people in the U.S. die due to CAD. In addition, as per the National Institutes of Health, an estimated 18.2 million adults in the country have CAD.

Reasons to subscribe to U.S. clot management devices market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. clot management devices market databook

  • Our clientele includes a mix of clot management devices market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. clot management devices market , including forecasts for subscribers. This country databook contains high-level insights into U.S. clot management devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. clot management devices market size, by product, 2018-2030 (US$M)

U.S. Clot Management Devices Market Outlook Share, 2023 & 2030 (US$M)

U.S. clot management devices market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more